Viral Vector Manufacturing
Virotherapy production is a complex, multi-stage process. We utilize our viral vector expertise and over 15 years of live viruses manufacturing experience to meet the rising demand for complex viral-based products.
As viral vector manufacturing experts, Vibalogics offers expertise in cell and virus banking, drug substance & drug product, and fill-finish.
Manufacturing – Areas of Expertise
Cell & Virus Banking
High-quality master and working cell and virus seed banking services provide critical starting materials for clinical-and-commercial supply.
Vibalogics specializes in the manufacture of high-quality GMP and non-GMP cell and virus banks in multiple expansion formats and sizes to provide the critical starting materials for your production process. We achieve successful clinical manufacturing and release time after time for our clients requiring reliable starting material generation.Find out more
Drug Substance & Drug Product
Single-use production technologies, adherent and suspension processes from 50-2000L scale.
For usage in a variety of regulatory environments around the world, Vibalogics has decades of experience producing live viruses and viral vectors under GMP and non-GMP virus manufacturing conditions, including oncolytic viruses, gene therapies, and vaccines. Our preclinical-through-commercial virotherapy manufacturing services are fully-robust, as we understand the complexity involved in the multistage process of manufacturing viral therapies.Find out more
Liquid and lyophilized fillings for up to 40,000k vial batches in high-throughput fill lines by Bosch, Bausch+Ströbel, and Vanrx.
Our dedicated aseptic fill-finish operators are available to provide a thorough and fast solution via semi- and fully-automated solutions with small-to-high-throughput capabilities, whether it be as a part of your manufacturing project or as a stand-alone service. From drug product to final container, our fully-integrated and seamless clinical supply services reduce risk, while our team has unmatched experience with drug product manufacture and fill, reducing costs and mitigating risk.Find out more